| Business Summary | | Amerisource
Bergen
Corporation,
formed
as
the
result
of
a
merger
of
equals
between
AmeriSource
Health
Corporation
and
Bergen
Brunswig
Corporation,
operates
in
two
business
segments,
pharmaceutical
distribution
and
PharMerica.
Pharmaceutical
distribution
includes
the
Company's
core
wholesale
pharmaceutical
drug
distribution
business,
ASD
Specialty
Healthcare,
the
Company's
pharmaceutical
alternate
site
distribution
business,
and
American
Health
Packaging,
its
pharmaceutical
repackaging
business.
Pharmaceutical
distribution
also
includes
a
number
of
smaller
specialty
units
in
areas
such
as
management
reimbursement
consulting
services
and
third-party
logistics
services
for
pharmaceutical
manufacturers.
PharMerica
is
a
national
provider
of
institutional
pharmacy
services
in
long-term
care
and
alternate
site
settings.
PharMerica
also
provides
mail-order
pharmacy
services
to
chronically
and
catastrophically
ill
patients
under
workers'
compensation
programs. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | AmerisourceBergen
Corp.
is
a
wholesale
distributor
of
pharmaceuticals
and
related
healthcare
services
serving
its
customers
nationwide
through
21
drug
distribution
facilities
and
three
specialty
products
distribution
facilities.
For
the
nine
months
ended
6/01,
revenues
rose
20%
to
$10.31
billion.
Net
income
increased
26%
to
$89.2
million.
Results
reflect
revenue
growth
with
the
Veterans
Administration
and
Novation
group
purchasing
organization,
and
warehouse
efficiencies. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000
Compensation | | Pay | Exer | |
| Robert Martini Chairman | -- | -- | R. David Yost, 53 Pres,
CEO, Director | $1.2M | $720K | Neil Dimick CFO,
Exec. VP | -- | -- | Kurt Hilzinger, 40 COO,
Exec. VP | 745K | 1.2M | Charles Carpenter Sr.
VP and Pres of PharMerica | -- | -- | Dollar
amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|